Recent evidence suggests that sex differences in AD may be more strongly related to regional tau pathology (Buckley et al., 2020) with a longitudinal PET study revealing that women have an increased accumulation rate of tau pathology, even when adjusting for baseline tau load (Smith et al., 2020). The gene discussed is MAPT; the disease is Alzheimer disease.